E-LIB Suche - Ergebnisse für: Reeskamp, Laurens

1

Evinacumab Markedly Reduces Low-density Lipoprotein Cholest..:

Reeskamp, Laurens ; Greber-Platzer, Susanne ; Saheb, Samir...
Journal of Clinical Lipidology. 16 (2022) 1 - p. e19 , 2022

Link: https://doi.org/10.1016/..

2

The effect of evinacumab on LDL-C goal attainment in patien..:

Raal, Frederick J. ; Rosenson, Robert ; Reeskamp, Laurens...
Journal of Clinical Lipidology. 15 (2021) 5 - p. e7-e8 , 2021

Link: https://doi.org/10.1016/..

3

The Efficacy and Safety of Evinacumab in Homozygous Familia..:

Rosenson, Robert ; Raal, Frederick ; Reeskamp, Laurens...
Journal of Clinical Lipidology. 14 (2020) 4 - p. 552 , 2020

Link: https://doi.org/10.1016/..

4

Polygenic Risk Is Associated With Long-Term Coronary Plaque..:

Nurmohamed, Nick S. ; Shim, Injeong ; Gaillard, Emilie L....
JACC: Cardiovascular Imaging. , 2024

Link: https://doi.org/10.1016/..

5

Decreased LDL-Cholesterol Exposure Following ANGPTL3 Inhibi..:

Schonck, Willemijn A.M. ; Reijman, M. Doortje ; Wiegman, Albert...
JACC: Cardiovascular Imaging. , 2024

Link: https://doi.org/10.1016/..

6

LDLR variant classification for improved cardiovascular ris..:

Ibrahim, Shirin ; Hartgers, Merel L. ; Reeskamp, Laurens F....
Atherosclerosis. , 2024

Link: https://doi.org/10.1016/..

7

Evinacumab in homozygous familial hypercholesterolaemia: lo..:

Gaudet, Daniel ; Greber-Platzer, Susanne ; Reeskamp, Laurens F...
European Heart Journal. 45 (2024) 27 - p. 2422-2434 , 2024

Link: https://doi.org/10.1093/..

8

Enhanced identification of familial hypercholesterolemia us..:

Ibrahim, Shirin ; Nurmohamed, Nick S. ; Nierman, Melchior C....
Atherosclerosis. 393 (2024) - p. 117548 , 2024

Link: https://doi.org/10.1016/..

9

Unexpected gaps in knowledge of familial hypercholesterolae..:

Ibrahim, Shirin ; de Goeij, Jim N. ; Nurmohamed, Nick S....
Netherlands Heart Journal. 32 (2024) 5 - p. 213-220 , 2024

Link: https://doi.org/10.1007/..

10

Beyond early LDL cholesterol lowering to prevent coronary a..:

Ibrahim, Shirin ; Reeskamp, Laurens F ; de Goeij, Jim N...
European Journal of Preventive Cardiology. 31 (2024) 7 - p. 892-900 , 2024

Link: https://doi.org/10.1093/..

11

Long-Term Efficacy and Tolerability of PCSK9 Targeted Thera..:

Schonck, Willemijn A. M. ; Stroes, Erik S. G. ; Hovingh, G. Kees.
Drugs. 84 (2024) 2 - p. 165-178 , 2024

Link: https://doi.org/10.1007/..

12

Polygenic Background Modifies Risk of Coronary Artery Disea..:

Reeskamp, Laurens F. ; Shim, Injeong ; Dron, Jacqueline S....
JACC: Advances. 2 (2023) 9 - p. 100662 , 2023

Link: https://doi.org/10.1016/..

13

ANGPTL3 (Angiopoietin‐Like 3) Preferentially Resides on Hig..:

Kraaijenhof, Jordan M. ; Tromp, Tycho R. ; Nurmohamed, Nick S....
Journal of the American Heart Association. 12 (2023) 21 - p. , 2023

Link: https://doi.org/10.1161/..

14

Association Between Self‐Rated Medication Adherence and Adv..:

Ibrahim, Shirin ; Nurmohamed, Nick S. ; Collard, Didier...
Journal of the American Heart Association. 12 (2023) 22 - p. , 2023

Link: https://doi.org/10.1161/..

15

The Long-Term Efficacy and Safety of Evinacumab in Patients..:

Raal, Frederick J. ; Rosenson, Robert S. ; Reeskamp, Laurens F....
JACC: Advances. 2 (2023) 9 - p. 100648 , 2023

Link: https://doi.org/10.1016/..